A detailed history of Strategic Asset Management, LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Strategic Asset Management, LLC holds 6,000 shares of VXRT stock, worth $3,960. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,000
Previous 6,000 -0.0%
Holding current value
$3,960
Previous $21,000 38.1%
% of portfolio
0.02%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 20, 2022

BUY
$4.29 - $6.64 $4,290 - $6,640
1,000 Added 20.0%
6,000 $30,000
Q4 2021

Jan 26, 2022

SELL
$5.77 - $7.96 $2,308 - $3,184
-400 Reduced 7.41%
5,000 $31,000
Q3 2021

Nov 04, 2021

BUY
$6.67 - $9.8 $36,018 - $52,920
5,400 New
5,400 $38,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $83.5M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Strategic Asset Management, LLC Portfolio

Follow Strategic Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Asset Management, LLC with notifications on news.